Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin and depression: old problems and new data.

A Plaznik1, W Kostowski, T Archer

  • 1Department of Pharmacology and Physiology of the Nervous System, Psychoneurological Institute, Warsaw, Poland.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Implementation of a Colorectal Cancer.

Irish medical journal·2024
Same author

Chronic stress changes prepulse inhibition after amphetamine challenge: the role of the dopaminergic system.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018
Same author

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs.

Journal of veterinary pharmacology and therapeutics·2017
Same author

Corticotropin releasing factor receptor 1 antagonist differentially inhibits freezing behavior and changes gamma-aminobutyric acidergic activity in the amygdala in low- and high-anxiety rats.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2017
Same author

Work- related Stress, over-nutrition and cognitive disability.

La Clinica terapeutica·2017
Same author

Psychopathology and neoplastic disease: medico-social and medico-legal considerations.

La Clinica terapeutica·2017
Same journal

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Altered dorsal striatal subregional connectivity associated with distinct executive function deficits in first-episode, drug-naïve major depressive disorder: Evidence from functional connectivity and granger causality analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Chronic pain and stress: unravelling the common neuroinflammatory, immune and endocrine mechanisms for novel therapeutic approaches.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Predicting anhedonia and negative cognitive processing changes after 8-week SSRIs treatment in depression from individual differential structural covariance network.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Mapping intrinsic neural timescale alterations in major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Probiotics in reducing negative symptoms of schizophrenia: A systematic review and meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
See all related articles

Depression may involve changes in brain serotonin systems. Antidepressant drug action is linked to interactions between serotonin and catecholamine pathways, with noradrenaline playing a key role.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Depressive states are associated with alterations in brain serotonergic systems.
  • Understanding neurotransmitter interactions is crucial for developing effective treatments.

Purpose of the Study:

  • To summarize evidence linking serotonergic system dysfunction to depression.
  • To examine the interplay between serotonin (5-HT) and catecholamine pathways in antidepressant drug efficacy.
  • To investigate the role of noradrenaline (NA) in modulating serotonergic activity.

Main Methods:

  • Literature review and synthesis of existing evidence.
  • Analysis of neurochemical pathways involved in mood regulation.
  • Examination of pharmacological mechanisms of antidepressant action.

Related Experiment Videos

Main Results:

  • Evidence suggests significant alterations in serotonergic systems in depression.
  • Interactions between 5-HT and catecholamine pathways are integral to antidepressant effects.
  • Noradrenaline (NA) modulation of serotonergic activity is a key factor in antidepressant efficacy.

Conclusions:

  • Serotonergic system dysfunction is implicated in depression.
  • Antidepressant mechanisms involve complex interactions between multiple neurotransmitter systems.
  • Noradrenergic modulation of serotonin is a critical component of antidepressant action.